If a patient is allergic to cephalexin, are they also allergic to Augmentin (amoxicillin‑clavulanate)?

Cephalexin Allergy Does Not Automatically Mean Augmentin Allergy

A patient allergic to cephalexin is NOT automatically allergic to Augmentin (amoxicillin-clavulanate), though there is a small risk of cross-reactivity that depends on the specific type and severity of the cephalexin reaction.

Understanding Cross-Reactivity Between Cephalosporins and Penicillins

The key to understanding this relationship lies in the structural chemistry of these antibiotics:

• Cross-reactivity is primarily driven by R1 side chains, not the beta-lactam ring itself 1
• Cephalexin (a first-generation cephalosporin) shares an identical R1 side chain with amoxicillin 1
• This structural similarity creates a higher risk of cross-reactivity specifically between cephalexin and amoxicillin compared to other cephalosporin-penicillin combinations 1

Risk Stratification Based on Reaction Type

For Non-Anaphylactic Reactions to Cephalexin:

• The overall cross-reactivity rate between cephalosporins and penicillins is approximately 2-4.8%, far lower than the historically quoted 10% 1
• For aminocephalosporins like cephalexin in patients with confirmed aminopenicillin allergy, the cross-reactivity rate is higher at 16.45% (95% CI: 11.07-23.75) 1
• If the cephalexin reaction was mild (e.g., rash without systemic symptoms), Augmentin can often be given directly with appropriate monitoring 1

For Anaphylactic Reactions to Cephalexin:

• Penicillin skin testing followed by drug challenge should be performed prior to administering Augmentin 1
• This is a conditional recommendation with moderate certainty of evidence 1
• The FDA label for cephalexin warns that "cross-hypersensitivity among beta-lactam antibiotics has been clearly documented and may occur in up to 10% of patients" 2, though this figure is now considered outdated

Clinical Decision Algorithm

Step 1: Characterize the cephalexin reaction

• Anaphylaxis, angioedema, or hypotension? → Proceed to formal allergy evaluation 1
• Mild delayed rash or urticaria? → Lower risk, consider direct challenge 1
• Severe delayed reactions (DRESS, SJS/TEN, organ-specific)? → Absolute contraindication to all beta-lactams 1

Step 2: For non-severe reactions

• The shared R1 side chain between cephalexin and amoxicillin increases cross-reactivity risk 1
• Consider using a penicillin with a different side chain (e.g., penicillin V) if beta-lactam therapy is essential 1
• Alternatively, use a non-beta-lactam antibiotic 1

Step 3: For severe IgE-mediated reactions

• Refer for penicillin skin testing 1
• If skin testing is negative, proceed with graded drug challenge 1
• If skin testing is positive, consider desensitization if Augmentin is essential 1

Important Caveats

• The 10% cross-reactivity figure on package inserts is outdated and based on contaminated cephalosporin preparations from before 1980 1, 2
• Recent evidence shows that less than 5% of patients with reported penicillin allergy have true persistent allergy 3
• Patients with urticaria as their cephalexin reaction have higher rates of cross-reactivity (30.65% vs 8.11% for other symptoms) 4
• The risk of severe cross-reactivity in patients with low-risk penicillin allergies is extremely low 3

Practical Considerations

• Most patients labeled as "cephalexin allergic" can safely receive Augmentin after appropriate risk assessment 5, 3
• The shared side chain between cephalexin and amoxicillin means this specific pairing has slightly higher cross-reactivity than other cephalosporin-penicillin combinations 1, 3
• Avoiding Augmentin unnecessarily may lead to use of broader-spectrum or less effective antibiotics, increasing morbidity and antimicrobial resistance 1, 3

The bottom line: evaluate the type and severity of the cephalexin reaction first. For mild reactions, the risk of cross-reactivity with Augmentin is low but present due to shared side chains. For severe reactions, formal allergy evaluation is warranted before administering any penicillin 1.